Search research articles
Contact Us
Filters
Showing results (181-190 of 10,097) with videos related to
Page
of 1,010
Sort By:
Fortune
|
October 31, 2003
Why do drug companies fear this man?
John Simons
Fortune
|
February 27, 2004
Merck's man in the hot seat
John Simons
Fortune
|
June 13, 2003
Taking on Viagra
John Simons
Survey of Ophthalmology
|
September 1, 1983
Visual acuity norms in young children
K Simons
Evidence-Based Nursing
|
September 26, 2022
Child-parent-nurse triad and its influence on children's pain management
Joan Simons
Idrugs : the Investigational Drugs Journal
|
September 13, 2005
Novel vascularization strategies
M Simons
Journal of the American College of Cardiology
|
September 6, 2005
Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?
Michael Simons
Fortune
|
June 25, 2005
Therapy that gets inside your head--literally
John Simons
Survey of Ophthalmology
|
March 8, 2005
Amblyopia characterization, treatment, and prophylaxis
Kurt Simons
Fortune
|
June 2, 2005
A new CEO'S RX for what ails Merck
John Simons
Page
of 1,010
Search research articles
Search
Showing results (181-190 of 10,097) with videos related to
Sort By:
Page
of 1,010
Fortune
|
October 31, 2003
Why do drug companies fear this man?
John Simons
Fortune
|
February 27, 2004
Merck's man in the hot seat
John Simons
Fortune
|
June 13, 2003
Taking on Viagra
John Simons
Survey of Ophthalmology
|
September 1, 1983
Visual acuity norms in young children
K Simons
Evidence-Based Nursing
|
September 26, 2022
Child-parent-nurse triad and its influence on children's pain management
Joan Simons
Idrugs : the Investigational Drugs Journal
|
September 13, 2005
Novel vascularization strategies
M Simons
Journal of the American College of Cardiology
|
September 6, 2005
Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?
Michael Simons
Fortune
|
June 25, 2005
Therapy that gets inside your head--literally
John Simons
Survey of Ophthalmology
|
March 8, 2005
Amblyopia characterization, treatment, and prophylaxis
Kurt Simons
Fortune
|
June 2, 2005
A new CEO'S RX for what ails Merck
John Simons
Page
of 1,010